A First-in-Human Multi-Part Phase 1 Study in Healthy Volunteers to Evaluate the Safety, Tolerability, Pharmacokinetics, and Drug-Drug Interaction Potential of Single and Multiple Doses of ALG-097558
Clinical trial NCT05840952 · COMPLETED
Trial details
- NCT number
- NCT05840952
- Sponsor
- Aligos Therapeutics
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-07-04
- Primary completion
- 2024-04-29
- Enrollment
- 90
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.